Navigation Links
Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results
Date:8/21/2008

%

Supplemental Information

related to Equity Compensation

Expense:

Equity Compensation Expense $0.7 $0.5

Equity Compensation Expense

Per Share (net of tax) $0.04 $0.03

Fiscal Year 2008 Results

Revenues: Sales and Royalties. Total revenues for the fiscal year ended June 30, 2008 were $79.8 million, up 15% from total revenues of $69.5 million for the fiscal year ended June 30, 2007.

Net sales increased 20% to $53.8 million from $44.9 million recorded in the prior fiscal year. Net sales of biomaterials products increased 16% to $47.5 million from $41.1 million, primarily due to orthopaedic product sales, which increased 35% to $29.4 million from $21.8 million. Sports medicine and spine product sales increased, 27% and 47%, respectively, over the prior fiscal year period. Sports medicine product sales were led by a 27% increase in product sales to the Company's most significant customer in this market. The increase in spine product sales included $2.0 million of new product sales resulting from the Company's MacroPore Biosurgery asset acquisition, completed in May 2007. Sales to Orthovita increased $1.9 million due to strong end user sales of existing products and initial shipments for the new VITOSS(R) Bioactive Foam product line launched by Orthovita in the second calendar quarter of 2008. Sales of vascular closure product components to St. Jude Medical decreased $1.8 million, or 10%, from the prior year period, as anticipated and previously disclosed.

Sales of endovascular products during the 2008 fiscal year increased 64% to $6.2 million from $3.8 million in the prior year. Endovascular sales included direct sales to customers through the month of May, as well as sales of product to Spectranetics during the month of June, after the Company's completion of the sale of its endovascular business (see below).

Royalty income for the fiscal year increased
'/>"/>

SOURCE Kensey Nash Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related biology technology :

1. Kensey Nash Corporation Announces Its Third Quarter 2008 Earnings Release Date and Teleconference
2. Kensey Nash Receives FDA 510(k) Clearance for New Safe-Cross(R) Vessel Wall Detection Technology
3. Kensey Nash to Present at the Canaccord Adams Small-Cap Orthopedics Conference
4. Kensey Nash to Participate in the Sidoti Fifth Annual Palm Beach Emerging Growth Institutional Investor Forum Conference
5. Kensey Nash to Participate in the RBC Capital Markets Healthcare Conference
6. Kensey Nash to Present at the Sidoti Sixth Annual West Coast Emerging Growth Institutional Investor Forum Conference
7. InstaCare Corp. Continues Turnaround & Reports 291% Revenues Increase in 2Q 2008
8. CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results
9. Expert Neurology Panel Weighs Impact of New Reports of PML in Multiple Sclerosis Patients on Tysabri
10. Arpida Reports Interim Results for Six Months to 30 June 2008
11. Rosetta Genomics Reports Second Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... SoundConnect is pleased to announce the release of ... Canada. Lync is the next generation of ... organizations to collaborate and communicate much more easily and ... United States. With the progressive rollout of Lync in ... SoundConnect now offers a complete Microsoft Lync solution for ...
(Date:5/21/2013)... 21, 2013 The Formulate Fusion Fabric ... for sales and marketing teams looking for a fully-functional package ... kit as “everything you’ll need to put together a stunning ... comes with a number of displays and accessories that can ... feet by 20 feet in size. These components vary from ...
(Date:5/20/2013)... -- , Collaboration with the U.S. ... in treatment of mastitis , Major ... begin in the second half 2013 ... Limited (ASX: POH, OTCQX: PPGNY) will collaborate with ... (ARS) to develop and trial products targeting the serious ...
(Date:5/20/2013)... Oven Industries Inc. announces a new laboratory ... controller has many outstanding user-friendly benefits. Contained all in ... wall as a self-contained temperature control system, which has ... device unique, as well as highly convenient for users. ... be used universally, which allows the user to use ...
Breaking Biology Technology:SoundConnect Announces Microsoft Lync Release in Canada 2SoundConnect Announces Microsoft Lync Release in Canada 3GLM Displays Announces All-in-One Formulate Fusion Fabric Display Kit 2Phosphagenics Signs Research Agreement with the Agricultural Research Service 2New Laboratory Temperature Controller by Oven Industries 2
... 4 ADVENTRX Pharmaceuticals,Inc. (Amex: ANX ), ... proprietary product candidates for the treatment,of cancer and ... chief executive officer is scheduled to present at ... September 10th, 2007,at 8:30 a.m. Eastern Daylight Time. ...
... given a 39 day shelf life, according to scientists speaking ... Microbiologys 161st Meeting at the University of Edinburgh, UK, which ... a maximum shelf life of three to four weeks (21-28 ... sliced meat in a supermarket. Currently cooked ham has 55% ...
... neurosurgical device,developer Elekta will feature the newest ... with clinical workflow solutions,that make neurosurgery more ... Neurosurgical Societies (EANS) European Congress September,2-7, 2007. ... professionals,will gather at the Scottish Exhibition & ...
Cached Biology Technology:ADVENTRX Pharmaceuticals to Present at the 20th Annual Bear Stearns Healthcare Conference 2Cooked ham with a 39 day shelf life 2Elekta Demonstrates Commitment to Stereotactic Innovation at EANS 2Elekta Demonstrates Commitment to Stereotactic Innovation at EANS 3Elekta Demonstrates Commitment to Stereotactic Innovation at EANS 4
(Date:5/21/2013)... become most deadly when they metastasize and spread tumors ... it becomes very difficult for doctors to locate and ... at the University of Missouri have found a way ... wherever they may be in the body. Michael Lewis, ... of Veterinary Medicine, says being able to target secondary ...
(Date:5/21/2013)... Researchers at the University of Illinois at Chicago College of ... and stores fat -- its main energy source -- and ... disease, under a new $2 million, 4-year grant from the ... heart changes how it uses fuel for energy. These changes ... disease and are different in men and women, says E. ...
(Date:5/21/2013)... the past few decades, scientists have developed many devices ... metallic stents. While generally effective, each of these treatments ... A new study from MIT analyzes the potential usefulness ... angioplasty balloons and drug-releasing stents, but may pose fewer ... in the artery for only a brief period, during ...
Breaking Biology News(10 mins):MU researchers develop radioactive nanoparticles that target cancer cells 2Do men's and women's hearts burn fuel differently? 2Evaluating a new way to open clogged arteries 2Evaluating a new way to open clogged arteries 3
... Chagas disease is the single most common cause of ... devastating parasitic infection affects millions of people throughout Central and ... greater threat in the United States and Europe as well. ... Trypanosoma cruzi , or T. cruzi , is the ...
... Fish oil is an underused ingredient in the food industry ... A new study in the February issue of the ... of Food Technologists, shows that fish oil can be added ... fatty acids without compromising taste or shelf-life. Fish oil ...
... is well understood that chromosomal translocation a process ... places is a hallmark of many cancers including ... part in how healthy cells become cancerous. The role ... repeatedly, however, has been a long-standing area of debate ...
Cached Biology News:UGA animal vaccine may slow deadly spread of Chagas disease 2UGA animal vaccine may slow deadly spread of Chagas disease 3Spatial proximity plays important role in chromosome translocation 2
... often call for critical, but time-consuming ... refines siRNA transfection protocols resulting in ... can be used to efficiently transfect ... without increased cytotoxicity. From start ...
... Gene silencing experiments often call for ... NeoFX Transfection Agent refines siRNA transfection ... NeoFXs lipid-based formulation can be used ... they are subcultured without increased ...
... special concentrated jetSI 10 nM is available ... mouse brain as described in: Z. Hassani, ... Giovannangeli, J.-P. Behr, and B.-A. Demeneix. Lipid-mediated ... in the mouse brain at picomolar levels. ...
... fluorescein-conjugated jetSI-ENDO (excitation at ... nm), the powerful siRNA transfection ... to determine the transfection efficiency ... and trafficking of siRNAs. More ...
Biology Products: